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INTRODUCTION
During the summer of 2011, an unusually high
number of cases displaying a similar syndrome among
cattle were first observed in Germany. Multiple farms
reported cows showing high fever (>40°C), milk drop
(to 50%), general depression, loss of appetite and in
some cases diarrhea. The Friedrich-Loeffler-Institut
(FLI), Federal Research Institute for Animal Health In-
vestigations in Germany, was the first laboratory to de-
tect unknown microbial genetic material in samples of
affected animals by means of metagenomic analysis.
Comparative genetic analysis indicated that this new
virus is very similar to certain members of the Or-
thobunyavirus genus. Moreover, the virus could be
isolated on insect cells and on a hamster cell line.
Based on the geographic origin of the samples, the new
virus was named “Schmallenberg virus”. Subsequently,
more severe symptoms were observed a few months af-
ter the primary onset of the disease. Abortions, still-
births and congenital malformations, such as arthro-
gryposis and hydranencephaly, were observed in
bovines, caprines, but especially in ovines. Germany,
the Netherlands, Belgium, Luxemburg, France, the
United Kingdom, Italy and recently Spain have mainly
reported cases in sheep, but also outbreaks on cattle and
goat farms have been reported. In March 2012, in Ger-
many, the Netherlands and Belgium, more than 750,
100 and 150 sheep farms respectively were found po-
sitive for the agent. Considering all these cases, it is
very likely that the viral agent and the symptoms are as-
sociated. At present, viral characteristics are being de-
Schmallenberg virus: emergence of an Orthobunyavirus among ruminants
in Western Europe 
Schmallenbergvirus: het opduiken van een Orthobunyavirus bij herkauwers
in West-Europa 
1L. Steukers, 2G. Bertels, 3A.B. Cay, 1H.J. Nauwynck
1Laboratory of Virology, Department of Virology, Parasitology and Immunology, Faculty of Veterinary
Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium
2Dierengezondheidszorg Vlaanderen (DGZ), Deinse Horsweg 1, B-9031 Drongen, Belgium
3Centrum voor Onderzoek in Diergeneeskunde en Agrochemie (CODA-CERVA),
Groeselenberg 99, B-1180 Ukkel, Belgium
lennert.steukers@ugent.be
ABSTRACT
Recently, a novel virus has been identified among ruminants in Western Europe. This virus, the so-called
Schmallenberg virus, belongs to the family Bunyaviridae, genus Orthobunyavirus, serogroup Simbu and is
closely related to Akabane, Aino and Shamonda virus. In cattle, acute symptoms in the dam and adult animals
generally include high fever, milk drop and diarrhea. More importantly, infection during gestation may lead
to abortion, stillbirth and congenital malformations. As all bunyaviruses, Schmallenberg virus also uses vec-
tors for efficient transmission. Closely related viruses causing similar symptoms, such as Akabane and Aka-
bane-like viruses, are mainly transmitted by Culicoides. It is very likely that Schmallenberg virus is transmitted
by similar vectors. This review provides an overview of Bunyaviridae, their epidemiology, symptoms, preven-
tion and control. Special emphasis is put on the Simbu serogroup of the Orthobunyavirus genus pointing out
the similarities between them and closely related members.
SAMENVATTING
Recent werd er een nieuw virus geïdentificeerd bij herkauwers in West-Europa. Dit virus, het Schmallenbergvi-
rus, behoort tot de familie Bunyaviridae, genus Orthobunyavirus, serogroep Simbu en vertoont sterke verwantschap
met het Akabane-, Aino- en Shamondavirus. Bij runderen bestaan de acute symptomen bij het moederdier en vol-
wassen dieren in het algemeen uit onder andere hoge koorts, milk drop en diarree. Opmerkelijk is het effect van het
virus op de foetus. Infectie tijdens de dracht kan aanleiding geven tot abortus, doodgeboorte en ernstige congenitale
malformaties. Net zoals alle andere bunyavirussen wordt Schmallenbergvirus overgedragen door vectoren. Gelijk-
aardige virussen, zoals Akabane en Akabane-achtige virussen, worden op die manier overgedragen door Culicoides.
Vermoedelijk zijn ook gelijkaardige vectoren van belang voor de transmissie van Schmallenbergvirus. Deze review
geeft een overzicht van Bunyaviridae, hun epidemiologie, symptomen, preventie en bestrijding. Speciale aandacht
gaat hierbij naar gelijkenissen tussen het Schmallenbergvirus en andere leden van de Simbu-serogroep.
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termined and thorough epidemiological research is on-
going. So far, there have been no indications for direct
zoonotic transmission from ruminants to humans for
this new pathogen (Beer, 2011; Gibbens, 2012). 
BUNYAVIRIDAE: A LARGE FAMILY OF SINGLE-
STRANDED AMBISENSE RNA VIRUSES
The family Bunyaviridae comprises more than 350
viruses including both animal and plant viruses. All
members are assigned to five different genera: Or-
thobunyavirus, Phlebovirus, Nairovirus, Hantavirus and
Tospovirus (Weber and Elliott, 2002; Savji et al., 2011).
Many bunyaviruses have no known medical or veteri-
nary significance, but some are classified as hazard level
3 or -4 pathogens. Some of these viruses, such as
Crimean-Congo hemorrhagic fever or Rift Valley fever,
cause incurable hemorrhagic fever with no available
preventive measures (Walter and Barr, 2011). In addition,
bunyaviruses are classified as emerging pathogens due
to their recent geographical movement and broadening
of the host range. 
All members are enveloped spherical RNA viruses
of about 120 nm in diameter. They all possess a tri-seg-
mented single-stranded genome and each of the seg-
ments, L (large), M (medium) and S (small) is con-
tained in a separate capsid within the virion. Although
these viruses predominantly use a negative coding
strategy during their cytoplasmic replication, some ge-
nomic parts consist of ambisense RNA, which allows
bi-directional coding. They encode for four structural
proteins: the viral polymerase (L), glycoproteins Gn
and Gc, and the nucleocapsid (N) protein. The open
reading frames (ORFs) for these proteins are located on
the L, the M and the S segments, respectively. Some
viruses possess additional ORFs on either the M or S
segment, encoding non-structural proteins that are des-
ignated NSm and NSs, respectively. The surface pro-
teins Gn and Gc play a role in the attachment and fu-
sion to the host cell and hemagglutination. However,
these particular proteins also evoke a strong humoral
immune response in the host that will finally eliminate
the virus. Viruses within each genus may display ad-
ditional similarities, such as segment size, protein size
and importantly nucleotide sequence, especially at the
3’ and 5’ ends. At these 3’ and 5’ termini of the seg-
ments, high complementary, non-translated regions
(NTRs) are present, allowing them to interact with
one another and therefore, segments exist as circular
molecules within the virion and infected cells. Fur-
thermore, these NTRs play an important role in seg-
ment function (Weber and Elliott, 2002; Grard et al.,
2011; Savji et al., 2011; Walter and Barr, 2011). A sig-
nificant property of RNA viruses in general is antigenic
drift. Due to the lack of a proof-reading function of the
viral RNA polymerase, point mutations occur at a
higher frequency than in DNA viruses. In addition, the
“repair” enzyme uracil-glycosylase, active on DNA
genomes, does not function on an RNA template. As a
result, spontaneous deamination of cytidine residues to
uracil occur more often in RNA and are another source
of at random point mutations (Moutailler et al., 2011).
These events lead to antigenic variation among Bun-
yaviridae and drive the formation of the so-called “es-
cape mutants”. These mutations enable the virus to es-
cape from the host immune system. Additionally,
bunyaviruses can exchange (part of) their genomes
during a mixed infection, also known as antigenic
shift. Similar to the case of Reoviridae (e.g. blue-
tongue virus), this genetic reassortment may lead to the
generation of new variants to which the host has not
been adapted yet. Alterations through both antigenic
drift and antigenic shift may have a major impact on
virulence, and inevitably cause emergence of new
viruses (Weber and Elliott, 2002). 
Bunyaviridae are transmitted by arthropods (mos-
quitoes, midges, ticks, thrips and sandflies), except
for members of the rodent-associated genus Han-
tavirus. It is clear that where the vector goes, the virus
will follow. Concerns have been raised over the ongo-
ing migration of several of these vectors in more
northerly regions of Europe, such as the occurrence of
the Hyalomma ticks, Culicoides midges and Aedes,
Culex and Anopheles mosquitoes in Europe and the
subsequent increase in cases of Crimean-Congo hem-
orrhagic fever virus, bluetongue virus and Rift Valley
fever virus infections, respectively (Mellor et al., 2008;
Walter and Barr, 2011). As the newly identified virus
Schmallenberg belongs to the genus Orthobunyavirus,
we will focus on this genus in the present article.
ORTHOBUNYAVIRUS TRANSMISSION AND EPI-
DEMIOLOGY 
The Orthobunyavirus genus contains over 170
viruses which are assigned to 48 distinct species, cov-
ering 18 different serogroups. Members within each
serogroup show complex antigenical relations. On the
one hand, they display weak cross-reactivity in hemag-
glutination inhibition and antibody neutralization tests.
On the other hand, they show serological relatedness by
complement fixation. Importantly, most serogroups
contain viruses with zoonotic potential. Based on se-
quence similarity, the recently isolated Schmallenberg
virus is classified as a member of the Simbu serogroup.
Currently, this group contains 25 different viruses iso-
lated from arthropod and vertebrate hosts from all over
the world, except Western Europe. At present, six par-
ticular members cause disease in either humans
(Oropouche and Iquitos virus) or ruminants (Akabane,
Aino, Shamonda and Schmallenberg virus) (Saeed et
al., 2001; Mores et al., 2009; Aguilar et al., 2011;
Savji et al., 2011; Gibbens, 2012). 
Similar to bluetongue virus (BTV), another viral
pathogen that emerged among ruminants in Western
Europe in 2006, most bunyaviruses belong to the group
of arthropod-borne viruses or Arboviruses (Purse et al.,
2005; Mellor et al., 2008). The majority of these
viruses are transmitted by different arthropods and
have one or more intermediate non-human vertebrate
hosts for amplifying cycles or geographical dissemi-
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nation (Hart et al., 2009; Walter and Barr, 2011). In
some vector species, venereal transmission is important
for spread in the insect population. In addition, verti-
cal transmission from infected females to progeny is a
cunning mechanism of the virus to overwinter and
persist within the vector. So far, these two transmission
mechanisms have been described for some members of
the orthobunyavirus genus in mosquito vectors
(Clements, 2012). An important factor in the efficient
transmission is the level of viremia postinfection in ver-
tebrates. Only if sufficient amounts of virus are circu-
lating in the blood, the virus may reach uninfected
hematophagous vectors during their blood meal and
spread rapidly in herds. Therefore, humans are usually
considered to be dead-end hosts. Humans may show
mild illness but viral titers in the blood rarely reach
high peaks (Saeed et al., 2001; Soldan and González-
Scarano, 2005; Hart et al., 2009; Hollidge et al., 2010;
Aguilar et al., 2011). So far, there have been no indi-
cations or reports of illness in humans due to Schmal-
lenberg virus. Simbu group orthobunyaviruses are par-
ticularly associated with ceratopogonid midges such as
Culicoides spp. Peak populations of the adult stage oc-
cur in late summer and autumn; therefore, acute symp-
toms caused by viruses transmitted by Culicoides are
prevalent during that period (Mellor et al., 2008;
Clements, 2012). Many different Culicoides species are
vectors in the transmission of orthobunyaviruses. For
example, members of the Avaritia subgenus, such as C.
brevitarsis and C. imicola, are vectors for Akabane,
Aino and Shamonda virus in the Mediterranean region,
Africa, Japan, Australia, as well as in other places
(Bishop et al., 2000; Stram et al., 2004; Yanase et al.,
2004). Normally, these vectors are not present in Eu-
rope. However, the emergence of BTV, which uses
similar vector species, in Western Europe in 2006, dis-
played an important alteration in the epidemiology of
this virus. The introduction of BTV in a naive area is
believed to occur in a number of different ways: these
include the movement of infected animals or animal
material and the movement of infected vectors, either
passively (by wind, airplanes, plants, animals, etc.) or
actively (climate change) with subsequent local propa-
gation (Wittmann and Baylis, 2000; Saegerman et al.,
2010). Firstly, it has been shown that, even before the
BTV-8 outbreak in Northwestern Europe in 2006,  im-
portant Afro-Asian vector species have migrated north-
wards but are not found in all the BTV-affected areas
of Europe (Wittmann and Baylis, 2000; Purse et al.,
2005; Mellor et al., 2008). Both climate change and in-
creasing international travel and transport seem to be
responsible for this ongoing vector migration (Walter
and Barr, 2011). Secondly and more importantly, other
Culicoides species, including other members of the
previously mentioned Avaritia subgenus all of which
are endemic in most parts of Northwestern Europe,
were responsible for the BTV-8 transmission in 2006
(Meiswinkel et al., 2008a, 2008b; Vanbinst et al.,
2009). Although a variety of mammal and avian
species may be targeted by these European endemic
midges, cattle have been shown to be the preferred host
for blood meals (Bartsch et al., 2009; Lassen et al.,
2011). 
PATHOGENESIS AND CLINICAL MANIFESTA-
TIONS CAUSED BY THE SIMBU SEROGROUP
The outcome of infection is different for inverte-
brates compared to vertebrates. Although the virus
replicates cytoplasmically, infection of mammalian
cells is cytolytic and results in cell death, whereas in-
fection of insect cells leads to persistence as no cyto-
pathic effects are visible postinfection (Hart et al.,
2009). 
The initial replication of the virus inside the vector
occurs in the midgut epithelium. Subsequently, the virus
disseminates into the hemocoel, permitting carriage in
the hemolymph. Finally, the virus enters cells of the sali-
vary glands, replicates and reaches the salivary ducts
(Clements, 2012). In ruminants, bunyaviruses replicate
in the periphery and cause a subsequent transient
viremia in their hosts. For Simbu group viruses, Aka-
bane virus is probably the best-studied member of the
viruses that may cause disease in ruminants. 
During the acute onset of infection with Akabane
virus in adult cattle, there are usually no overt clinical
signs. Viremia generally occurs one to six days after in-
fection and may last for two to six days (Charles,
1994). However, Schmallenberg virus seems to have a
more clinical acute onset, as is the case for Rift Valley
fever virus (RVFV) (Table 1). RVFV is a bunyavirus
that causes inappetence, diarrhea and fever among
other symptoms in cattle during the acute phase of in-
fection (Hollidge et al., 2010; Beer, 2011). Interest-
ingly, the level and severity of viremia often seem to be
age-dependent. Newborn animals develop higher titers
of viremia than adult animals (Weber and Elliott,
2002). However, a large-scale outbreak in Japan of neu-
rological symptoms in beef and dairy cattle of 4 to 96
months of age showed that virulent isolates that induce
a strong viremia are not age-restricted (Kono et al.,
2008). Because of the high plasma load, the virus is
able to cross the blood-brain barrier through an un-
known mechanism and cause severe encephalomyelitis
and death (Weber and Elliott, 2002). Both innate and
specific humoral immunity are important factors for vi-
ral clearance. Cell-mediated immunity seems to play a
minor role because infected cells are rapidly destroyed
by the viral infection itself (Pavlovic et al., 2000).
Type I interferon (IFN), produced by infected cells,
plays a major role in controlling the first critical
viremic phase of Bunyaviridae. As part of the innate
(aspecific) immunity, IFN primes neighboring cells to
express antiviral factors and therefore establishes a
first line of defense. In newborn animals, the interferon
system is not yet fully matured, which may in part ex-
plain the higher viremic load. If the host is able to con-
fine the virus, the adaptive immune system produces
specific neutralizing antibodies that are involved in the
viral clearance and the protection against recurrent in-
fections (Weber and Elliott, 2002). 
In pregnant cattle however, the short viremic phase
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creates a small opportunity for the virus to reach the fe-
tal circulation, thereby infecting the placenta. The virus
then multiplies in the rapidly dividing cells of the fe-
tus, especially in the fetal brain, spinal cord and skele-
tal muscle (Parsonson et al., 1982, 1988). For neuronal
tissues, it has been shown that neuronal and astroglia
cells are particularly susceptible to Akabane virus in-
fection, whereas microglia cells seem rather resistant
to infection (Kitani et al., 2000). The time of infection
relative to the stage of gestation determines the sever-
ity of developmental defects. When neuronal tissues
are differentiating, maximal damage occurs at ap-
proximately 30-50 days, 40 days and 60-90 days in
pregnant sheep, pregnant goats and pregnant cattle re-
spectively. The duration of infection of the fetus is de-
pendent on the ability of the fetal immune system to re-
act upon infection. Immunocompetence in calves de-
velops at approximately 90 days of gestation and in
lambs at 65 to 70 days of gestation (Parsonson et al.,
1977, 1981, 1985). The manifestation of the virus in
the fetus may result in various clinical symptoms,
which are quite similar for Akabane and Schmallen-
berg virus (Figures 1 to 7). Abortion in the third
trimester might be observed in case of acute infection
of pregnant animals. However, most symptoms are
seen some time after initial infection in the dam. They
include abortion, stillborn calves or calves that are de-
livered alive premature or at term, with various intra-
uterine congenital malformations. As mentioned
above, fetal damage is dependent on the time of in-
Table 1. Comparison of two closely related Simbu group orthobunyaviruses in ruminants.
Akabane virus Schmallenberg virus
Genus Orthobunyavirus Orthobunyavirus
Serogroup Simbu Simbu
Geographical location Africa, Asia and Oceania Europe
Vector Culicoides imicola Culicoides obsoletus
Culicoides brevitarsis Culicoides dewulfi
Culicoides wadei Culicoides pulicaris
Culicoides oxystoma Culicoides imicola?
Culicoides milnei Aedes, Culex and Anopheles?
(Aedes, Culex and Anopheles)
Host range Cattle Cattle
Sheep Sheep
Goats Goats
Wild ruminants ?
(Dogs, Horses, Camels)
Incubation period 1-6 days ?
Viremia duration 4-6 days 2-6 days
Acute symptoms (adult animals) Subclinical In cattle: high fever (>40,5°C),
loss of appetite, loss of condition,
milk drop, diarrhea
Effect on fetus (symptoms) Arthrogryposis, torticollis, Arthrogryposis, torticollis, 
scoliosis, kyphosis, scoliosis, kyphosis, 
brachygnathism, muscular hypoplasia, brachygnathism, muscular hypoplasia
fibrinous polyarticular synovitis +?
Hydranencephaly, microencephaly, Hydranencephaly, microencephaly, 
porencephaly, agenesis of the cerebrum, porencephaly, agenesis of the
hydrocephalus, fibrinous leptomeningitis cerebrum and possible cerebellum, 
and ependymitis, agenesis/hypoplasia hydrocephalus, agenesis/hypoplasia 
of the spinal cord of the spinal cord
+?
Lung hypoplasia, Lung hypoplasia
fibrinous navel infection, +?
erosions muzzle and interdigital erosions,
cataract, presternal steatosis
Diagnosis Virus isolation, RT-PCR, HI, Virus isolation, RT-PCR
SN, ELISA (serology)
Vaccines Yes Not yet
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Figure 1. Typical clinical image of a newborn affected
by Schmallenberg virus infection. 
Figure 2. Hydranencephaly caused by Schmallenberg
virus in a newly born lamb. 
Figure 3. Histopathological image of the spinal cord of a
lamb affected by Schmallenberg virus. Although the cen-
tral canal is clearly visible, severe neuronal loss in both
dorsal and ventral gray matter of the spinal cord are
prominent. 
Figure 4. Intra-uterine Schmallenberg virus infection of
a neonatal calf.
Figure 5. Severe arthrogryposis in a newborn lamb caused
by Schmallenberg virus. Notice the severe ankylotic joints
in the hind limbs. (Picture by K. Van der Sypt)
Figure 6. Torticollis is often present due to infection with
Schmallenberg virus, as seen in this newborn lamb. (Pic-
ture by K. Van der Sypt)
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fection during gestation. Infection during the first
trimester results in grossly deformed fetuses, mostly
dead at birth with limbs locked in extension or flexion.
Most live neonates have central nervous disorders rang-
ing from dullness, blindness and deafness to severe
paralysis and incoordination. Within the central ner vous
system, hydranencephaly, hydrocephalus, agenesis of
the brain, microencephaly, porencephaly and cerebellar
cavitation, etc. have been variously reported. The cere-
bellum however, remains unaffected after Akabane in-
fection, but Schmallenberg virus can cause agenesis or
hypoplasia of the cerebellum. Additionally, muscu-
loskeletal abnormalities, including arthrogryposis, tor-
ticollis, scoliosis, brachygnathism and kyphosis, are
often observed. Veterinarians should remain vigilant of
the fact that dystocia at parturition may occur owing to
the deformities in the fetus (Whittem, 1957; Kurogi et
al., 1977; Parsonson et al., 1977, 1981). The final clin-
ical image of a newborn depends on how many limbs
are involved and, more importantly, how many of the
higher functions are impaired because of the brain le-
sions. Even when the cerebrum is entirely absent, all vi-
tal functions may be intact and the neonates can possi-
bly stand and walk independently. Exceptionally, some
of them have been reared to maturity and have calved
in a normal way (Parsonson et al., 1977, 1981).
DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
A sudden onset of clustered cases of abortion, pre-
mature and at term, live or stillborn fetuses with arthro-
gryposis and hydranencephaly suggests a teratogenic
virus as possible cause. Next to orthobunyaviruses,
bluetongue virus, bovine viral diarrhea virus and bor-
der disease virus causing hydranencephaly, cerebellar
dysplasia and hairy shaker lambs respectively, should
be considered as potential causative agents (Osburn and
Castrucci, 1991; Nettleton et al., 1998; Vercauteren et
al., 2008; De Clercq et al., 2008). The results of diag-
nostic tests and the subclinical or mild clinical symp-
toms in the dam are suggestive for Orthobunyavirus in-
fection. 
The detection of virus specific antibodies is often
used as a diagnostic tool and is useful in virus epi-
demiology. Seroconversion in the dam and the presence
of antibodies in precolostral fetal serum confirm recent
bunyavirus infection. Serum neutralization (SN) and
hemagglutination inhibition (HI) tests have been used
extensively for this purpose and have proved to be
specific and sensitive, especially SN. In addition, dif-
ferent enzyme-linked immunosorbent assays (ELISAs)
are available. However, in view of cross reactivity and
diagnostic accuracy, it is important to validate these
tests (Tsuda et al., 2004; Paweska et al., 2007). 
For etiological diagnosis, traditional virus isolation
from placenta and affected fetal tissues, such as nerv-
ous tissues and cerebrospinal fluid, may be considered,
although it rarely generates a positive result. If adult an-
imals show clinical symptoms during the acute stage of
infection, virus isolation from blood samples might
show positive results. Cell lines derived from different
species are susceptible to bunyaviruses. Simbu group
orthobunyaviruses can be grown on monkey kidney
(Vero), hamster lung (HmLu-1) and baby hamster kid-
ney (BHK-21) cells, among others (Coetzer and Tustin,
2004; Aguilar et al., 2011; Kim et al., 2011). Diagnos-
tics for detection of the virus can also be performed by
using reverse transcriptase polymerase chain reaction
(RT-PCR), both conventional and quantitative. More-
over, RT-PCR is a rapid and sensitive method that is be-
ing increasingly used as a supplement to serology for
the diagnosis of Arboviruses (Wang et al., 2009).
CONTROL AND ERADICATION
At present, no therapeutics are available for bunya-
virus-induced diseases and supportive treatment is lim-
ited. Although some bunyaviruses seem to be ham-
pered by the antiviral drug ribavirin, the majority,
including Simbu group orthobunyaviruses, remain un-
affected (Livonesi et al., 2006; Flusin et al., 2011). In-
terestingly, RNA interference by siRNAs has been
shown to be a potential candidate to interfere with in-
fections caused by Bunyaviridae including Akabane
virus (Levin et al., 2006). However, especially for
livestock, prophylactic measures remain of major im-
portance for practical and economical reasons. In Ko-
rea and Japan, vaccines against Akabane virus are
Figure 7. Newborn lamb showing severe inferior
brachygnathism due to Schmallenberg virus infection in
utero. (Picture by K. Van der Sypt)                          
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commercially available (Kim et al., 2011). In Aus-
tralia, an effective killed vaccine against Akabane virus
has been developed but has not been marketed yet
(Kirkland and Barry, 1986). The purpose of these vac-
cines is to induce specific neutralizing antibodies
against the virus in the dam, thereby preventing the
virus from reaching the fetus. Studies conducted with
La Crosse virus, an orthobunyavirus within the Cali-
fornia serogroup, have shown that especially glyco-
protein G1 induces neutralizing antibodies that give a
protective immune response (Pekosz et al., 1995). Im-
portantly, animals that are naturally infected with Ak-
abane virus, seem to develop a strong immunity which
may last for a few years. Therefore, an alternative
strategy is to move susceptible animals to endemic re-
gions to develop immunity before they are first bred.
Moreover, for neonatal calves, especially for beef
calves, it has been shown that Akabane specific anti-
body enriched colostrum provides a decent maternal
immunity. Approximately 4.8 months is the estimated
age when the maternal antibodies decay with a 90%
probability (Tsutsui et al., 2009). Vaccines should be
administered before and during gestation, prior to the
exposure to infected vectors, in order to be effica-
cious. Other preventive measures focus on control of
the vector. Disruption of breeding sites, reduction of
vector population through pesticide use and protection
of ruminants by repellents are possible additional meas-
ures but are more labor intensive (Clements, 2012).
ZOONOTIC POTENTIAL
At least 30 different orthobunyaviruses may cause
disease in humans, and symptoms range from mild
febrile illness to severe encephalitis and hemorrhagic
fever. The symptoms in humans are mainly observed
during the period of vector activity. In most cases how-
ever, humans are accidentally infected by the vector and
thus considered to be dead-end hosts, showing mild ill-
ness and a low viremia. Subsequently, further spread to
uninfected vectors and humans is not observed. Ex-
ceptions may be found within the Simbu serogroup or-
thobunyaviruses. Oropouche and Iquitos viruses are
causative agents of large epidemics of febrile illness
among humans (Hart et al., 2009; Aguilar et al., 2011).
So far, other members of the Simbu group, such as Ak-
abane, Aino and Shamonda, have only been found in
livestock. Nevertheless, as a group, orthobunyaviruses
have zoonotic potential because a large number of or-
thobunyaviruses can cause disease among humans.
Therefore, zoonotic potential cannot be excluded, al-
though it is unlikely (Hart et al., 2009). Interestingly, the
non-structural protein NSs is responsible for antago-
nizing the IFN response during infection. As the abil-
ity to counteract and overcome the host innate immune
response is considered to be of importance for delin-
eating host range, the NSs protein is a factor that drives
the zoonotic capacity of orthobunyaviruses (Hart et
al., 2009). So far, no unusual illness in humans due to
the Schmallenberg virus has been reported. 
CONCLUSIONS AND FUTURE DIRECTIONS
The emergence of Schmallenberg virus among ru-
minants in Western Europe, an Akabane-like Simbu
group Orthobunyavirus, confirmed once again that Ar-
boviruses are excellent paradigms for emerging and re-
emerging diseases. Different factors, such as
vector/host dynamics, climate and immune status of the
population, play a role in the Arbovirus life cycle. Cli-
mate change is thought to be a key player in spread of
Arboviruses. A higher average temperature increases
vector populations, and more importantly, allows
changes in vector range and vertebrate hosts (Hollidge
et al., 2010). Since the emergence of bluetongue in
2006, it has become clear that, despite the clear ex-
pansion northwards of C. imicola, which had already
been observed before 2006, the range of BTV has
spread beyond the range of this Afro-Asian vector,
thereby suggesting that novel vector species might be
contributing to transmission. Recent studies have con-
firmed that endemic Culicoides contribute to the ob-
served spread (Meiswinkel et al., 2008a, 2008b; Van-
binst et al., 2009). Although speculative at the moment,
it is very plausible that the evolution of the spread of
Schmallenberg virus and that of bunyaviruses in gene-
ral are very similar. 
At present, it is still unclear whether this exotic virus
has been newly introduced or whether orthobunyaviruses
have already been present in ruminants and vectors in
Europe for some time. To address this question, it might
be worth reinvestigating the acquired vectors from the
BTV vector surveys for Orthobunyavirus presence.
Another interesting question is how spread from the
tropical vector to the endemic vector exactly happens.
A straightforward approach would be to introduce the
virus in a naive vector population, which may be sus-
ceptible to sustain infection but which has never been
exposed to this virus family before. However, if en-
demic Culicoides do not possess correct entry receptors
for those viruses, mating of local species with the
newly immigrant tropical vectors might result in hybrid
progeny that allows viral infection and subsequent
persistence. Elucidating these aspects may be instru-
mental in attaining better control of these emerging dis-
eases. 
Stimulating immunity by use of vaccines is an-
other way of controlling viruses. Humoral immunity
plays a major role in controlling orthobunyaviruses,
and for certain Simbu group members such as Akabane
virus vaccines have been developed (Kim et al., 2011).
However, the production of vaccines takes time, and
importantly, vaccines must be safe and their use needs
to be economically justified. Considering the epi-
demiology of Schmallenberg virus, the virus is likely
to recur during the vector season of 2012. In this event,
it will be important to monitor these expected out-
breaks. 
There is an urgent need for profound research to im-
prove the present knowledge in order to solve ambi-
guities such as: are animals that were infected in 2011
immune and (lifelong) protected? Are vaccines neces-
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sary, if natural infection may occur and immunize an-
imals before fertilization and gestation? May the virus
be transmitted through contact with for instance am-
niotic fluid? May zoonotic transmission of Schmal-
lenberg virus be firmly excluded? 
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